KEYWORD

clinical trials

Dr. Steve Goldstein

UCI is among founding members of national coalition to improve clinical trials

ACT@POC aims to boost efficiency, accessibility and participant diversity to benefit patients

Dr. Krishnansu Tewari

UCI receives record $592 million in research funding for fiscal 2020-21

12 percent more than last year, amount reflects strong support for campus mission

Advancing breakthrough science

Sue & Bill Gross Stem Cell Research Center celebrates 10 years of innovation

Dr. Daniela Bota, medical director of the UCI Center for Clinical Research standing in her lab

Revving up research

Year-old center for accelerating clinical trials gave UCI Health an investigative edge when the pandemic hit

Dr. Richard Lee, interim chief of UCI Health’s Division of Pulmonary Diseases and Critical Care Medicine principal investigator for the Aviptadil clinical trial.

UCI to take part in clinical trial of drug for critically ill COVID-19 patients

Aviptadil could save people suffering from acute respiratory distress syndrome

UCI neuroscientist and professor of otolaryngology John Middlebrooks

An improved implant

UCI researchers have developed a breakthrough cochlear device that could enable hearing-impaired people to detect pitch

The Alzheimer’s crunch

With jump in patients expected, new leader of clinical research operations at UCI MIND aims to accelerate translation of discoveries into effective treatments

Dr. Dan M. Cooper, director of UCI’s Institute for Clinical & Translational Science

UCI Institute for Clinical & Translational Science receives $24 million NIH grant

Funding continues campus effort to speed scientific discoveries into medical advances

Leslie Thompson gets $6 million CIRM grant to advance Huntington’s disease treatments

Leslie Thompson of the Sue & Bill Gross Stem Cell Research Center and UCI MIND has been awarded $6 million by the California Institute for Regenerative Medicine to continue her CIRM-supported efforts to create stem cell treatments for Huntington’s disease. The funding will allow the Thompson lab to conduct the late-stage testing needed to apply […]

Professor Henry Klassen

FDA greenlights UCI clinical trial of treatment for blinding disease

A first-of-its-kind stem cell-based treatment for retinitis pigmentosa developed by UC Irvine’s Dr. Henry Klassen, Dr. Jing Yang and colleagues has received consent from the U.S. Food & Drug Administration for use in a clinical trial.